In a report released today, Raju Prasad from William Blair maintained a Buy rating on Celyad (CYAD – Research Report).
Category: Healthcare
Analysts Offer Insights on Healthcare Companies: Equillium (NASDAQ: EQ) and Siemens Healthineers AG (Other OTC: SEMHF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Equillium (EQ
Autolus Therapeutics (AUTL) Receives a Buy from Needham
In a report released today, Chad Messer from Needham maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report),
Mizuho Securities Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Autolus Therapeutics (AUTL – Research
B.Riley Financial Reaffirms Their Buy Rating on X4 Pharmaceuticals (XFOR)
In a report released today, Mayank Mamtani from B.Riley Financial maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research
William Blair Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
William Blair analyst Raju Prasad maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s
Needham Issues a Buy Rating on Aerie Pharma (AERI)
In a report released today, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report),